A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread

Clinical trial NCT01648764 · COMPLETED

Trial details

NCT number: NCT01648764
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Solid Tumor Solid Tumor Metastatic Tumor

Start date: 2008-09-01
Primary completion: 2012-11-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.